Publications

Title

Author

Year

Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: A phase II randomized study.

ODUTOLA, A; Ota, MO; Ogundare, EO; ANTONIO, M; Owiafe, P; Worwui, A; GREENWOOD, B; Alderson, M; Traskine, M; Verlant, V; Dobbelaere, K; Borys, D;

2015

Human vaccines & immunotherapeutics, (2015).12 2 10.1080/21645515.2015.1111496.

HPV vaccine introduction in Rwanda: Impacts on the broader health system.

TORRES-RUEDA, S; Rulisa, S; BURCHETT, HE D; Mivumbi, NV; MOUNIER-JACK, S;

2015

Sexual & reproductive healthcare, (2015).7, 10.1016/j.srhc.2015.11.006.

Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola.

Moon, S; Sridhar, D; Pate, MA; Jha, AK; Clinton, C; Delaunay, S; Edwin, V; Fallah, M; Fidler, DP; Garrett, L; Goosby, E; Gostin, LO; HEYMANN, DL; Lee, K; Leung, GM; Morrison, JS; Saavedra, J; Tanner, M; Leigh, JA; HAWKINS, B; Woskie, LR; PIOT, P;

2015

Lancet, (2015).386 10009 10.1016/S0140-6736(15)00946-0.

Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study.

NGUIPDOP-DJOMO, P; Heldal, E; RODRIGUES, LC; Abubakar, I; MANGTANI, P;

2015

The Lancet infectious diseases, (2015).16 2 10.1016/S1473-3099(15)00400-4.

Prevention of bacterial infections in the newborn by pre-delivery administration of azithromycin: Study protocol of a randomized efficacy trial.

ROCA, A; Oluwalana, C; CAMARA, B; BOJANG, A; BURR, S; Davis, TM E; BAILEY, R; KAMPMANN, B; Mueller, J; BOTTOMLEY, C; D'ALESSANDRO, U;

2015

BMC pregnancy and childbirth, (2015).15 1 10.1186/s12884-015-0737-3.

The PneuCarriage Project: A Multi-Centre Comparative Study to Identify the Best Serotyping Methods for Examining Pneumococcal Carriage in Vaccine Evaluation Studies.

Satzke, C; Dunne, EM; Porter, BD; Klugman, KP; MULHOLLAND, EK; PneuCarriage project group,;

2015

PLoS medicine, (2015).12 11 10.1371/journal.pmed.1001903.

Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia.

ROCA, A; BOJANG, A; BOTTOMLEY, C; Gladstone, RA; Adetifa, JU; Egere, U; BURR, S; ANTONIO, M; Bentley, S; KAMPMANN, B; Pneumo13 Study Group,;

2015

Vaccine, (2015).33 51 10.1016/j.vaccine.2015.11.012.

Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.

RHODES, SJ; KNIGHT, GM; FIELDING, K; Scriba, TJ; Pathan, AA; McShane, H; FLETCHER, H; WHITE, RG;

2015

Tuberculosis (Edinburgh, Scotland), (2015).96, 10.1016/j.tube.2015.10.002.

Implementation of the malaria candidate vaccine RTS,S/AS01.

GREENWOOD, B; Doumbo, OK;

2015

Lancet, (2015).387 10016 10.1016/S0140-6736(15)00807-7.

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.

Penny, MA; Verity, R; Bever, CA; Sauboin, C; Galactionova, K; FLASCHE, S; White, MT; Wenger, EA; Van de Velde, N; Pemberton-Ross, P; Griffin, JT; Smith, TA; Eckhoff, PA; Muhib, F; JIT, M; Ghani, AC;

2015

Lancet, (2015).387 10016 10.1016/S0140-6736(15)00725-4.